4.35
price down icon3.33%   -0.15
pre-market  Vorhandelsmarkt:  4.47   0.12   +2.76%
loading
Schlusskurs vom Vortag:
$4.50
Offen:
$4.52
24-Stunden-Volumen:
1.17M
Relative Volume:
0.81
Marktkapitalisierung:
$91.59M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+74.00%
1M Leistung:
+383.33%
6M Leistung:
+278.26%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$4.06
$4.86
1-Wochen-Bereich:
Value
$2.37
$6.19
52-Wochen-Spanne:
Value
$0.5506
$6.19

Citius Oncology Inc Stock (CTOR) Company Profile

Name
Firmenname
Citius Oncology Inc
Name
Telefon
(908) 967-6677
Name
Adresse
11 COMMERCE DRIVE, CRANFORD
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
CTOR's Discussions on Twitter

Vergleichen Sie CTOR mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
CTOR
Citius Oncology Inc
4.35 91.59M 0 0 0 0.00
Drug Manufacturers - Specialty & Generic icon
RGC
Regencell Bioscience Holdings Ltd
17.04 303.95B 0 -5.87M -767.30K -0.45
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
155.95 74.39B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.37 48.97B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.46 47.39B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.76 20.17B 16.54B -1.64B 749.00M -1.45

Citius Oncology Inc Stock (CTOR) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-11-27 Eingeleitet Maxim Group Buy

Citius Oncology Inc Aktie (CTOR) Neueste Nachrichten

pulisher
Jun 17, 2025

Citius Oncology prepares for lymphoma treatment launch in 2025 By Investing.com - Investing.com Nigeria

Jun 17, 2025
pulisher
Jun 17, 2025

Citius Oncology On Track to Launch Lymphir in US in H2 - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

Citius Oncology prepares for lymphoma treatment launch in 2025 - Investing.com

Jun 17, 2025
pulisher
Jun 17, 2025

Citius Oncology Anticipates Commercial Launch of LYMPHIR™ in 2025 - StreetInsider

Jun 17, 2025
pulisher
Jun 13, 2025

Citius Oncology enters distribution services agreement with Cardinal Health - MSN

Jun 13, 2025
pulisher
Jun 13, 2025

Citius Pharmaceuticals Announces Closing of Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules - The Victoria Advocate

Jun 13, 2025
pulisher
Jun 13, 2025

Citadel Advisors LLC Makes New $26,000 Investment in Citius Oncology, Inc. (NASDAQ:CTOR) - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

After Major Oncology Conference, All Eyes Turn to Industry Innovation - Cantech Letter

Jun 12, 2025
pulisher
Jun 12, 2025

Citius Pharmaceuticals Announces a Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules - Longview News-Journal

Jun 12, 2025
pulisher
Jun 10, 2025

Citius Pharmaceuticals Secures $15.8M Strategic Financing: LYMPHIR Commercial Launch Gets Green Light - Stock Titan

Jun 10, 2025
pulisher
Jun 09, 2025

Citius Oncology partners with Cardinal Health for LYMPHIR distribution By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Oncology Enters Into Distribution Services Agreement With Cardinal Health - MarketScreener

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Oncology Signs US Distribution Deal With Cardinal Health for Lymphir - marketscreener.com

Jun 09, 2025
pulisher
Jun 09, 2025

Cardinal Health (CAH) Partners with Citius Oncology for LYMPHIR Distribution | CAH Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Oncology Inks Distribution Services Agreement With Cardinal Health For LYMPHIR - Nasdaq

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Oncology stock soars on distribution deal By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Oncology stock soars on distribution deal - Investing.com

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Oncology partners with Cardinal Health for LYMPHIR distribution - Investing.com

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Oncology Enters into Distribution Services Agreement with Cardinal Health | CTXR Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Citius Oncology Enters into Distribution Services Agreement with Cardinal Health - Yahoo Finance

Jun 09, 2025
pulisher
Jun 06, 2025

Citius Oncology (NASDAQ:CTOR) Trading Up 3.4% – Here’s Why - Defense World

Jun 06, 2025
pulisher
May 23, 2025

This Deckers Outdoor Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Benzinga

May 23, 2025
pulisher
May 23, 2025

Maxim Downgrades Citius Oncology to Hold From Buy - marketscreener.com

May 23, 2025
pulisher
May 14, 2025

Citius Oncology (CTXR) Seeks Additional Capital for LYMPHIR Laun - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Citius Oncology (CTXR) Seeks Additional Capital for LYMPHIR Launch | CTXR Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Citius Oncology, Inc. Reports Fiscal Second Quarter 2025 Financial Results And Provides Business Update - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update - PR Newswire

May 14, 2025
pulisher
May 14, 2025

Citius Pharmaceuticals Reports Critical Cash Position, Advances FDA-Approved LYMPHIR Launch Strategy - Stock Titan

May 14, 2025
pulisher
May 07, 2025

Citius Oncology, Inc. (NASDAQ:CTOR) Is Expected To Breakeven In The Near Future - Yahoo Finance

May 07, 2025
pulisher
May 05, 2025

Citius Pharmaceuticals to Present at the Jefferies Global Healthcare Conference | CTXR Stock News - GuruFocus

May 05, 2025
pulisher
May 05, 2025

Citius Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - PR Newswire

May 05, 2025
pulisher
May 05, 2025

Citius Pharmaceuticals to Present at the Jefferies Global Health - GuruFocus

May 05, 2025
pulisher
Apr 26, 2025

US Stocks Dip As Investors Eye Trump's Tariff Announcements - Finimize

Apr 26, 2025
pulisher
Apr 25, 2025

Citius Oncology IncReceives Nasdaq Notice For Bid Price Non-ComplianceSEC Filing - marketscreener.com

Apr 25, 2025
pulisher
Apr 23, 2025

Citius Oncology (NASDAQ:CTOR) Trading 6.3% Higher – Still a Buy? - Defense World

Apr 23, 2025
pulisher
Apr 04, 2025

Citius Pharmaceuticals Announces $2 Million Registered Direct Offering of Common Stock - Longview News-Journal

Apr 04, 2025
pulisher
Apr 02, 2025

Citius Oncology Inc (NASDAQ: CTOR) Is On The Fall - stocksregister.com

Apr 02, 2025
pulisher
Apr 01, 2025

Citius Pharma secures $2 million in stock offering By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

Citius Pharma secures $2 million in stock offering - Investing.com India

Apr 01, 2025
pulisher
Apr 01, 2025

Citius Oncology (NASDAQ:CTOR) Shares Up 39.8% – Still a Buy? - Defense World

Apr 01, 2025
pulisher
Apr 01, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Apr 01, 2025
pulisher
Apr 01, 2025

3 Penny Stocks to Watch Now, 4/1/25 - TipRanks

Apr 01, 2025
pulisher
Mar 31, 2025

Why Citius Oncology Inc. Stock Spiked Over 7%? - timothysykes.com

Mar 31, 2025
pulisher
Mar 31, 2025

Why Xos Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga

Mar 31, 2025
pulisher
Mar 24, 2025

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

Mar 24, 2025

Finanzdaten der Citius Oncology Inc-Aktie (CTOR)

Es liegen keine Finanzdaten für Citius Oncology Inc (CTOR) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$14.28
price down icon 0.07%
$8.93
price down icon 0.89%
$125.69
price up icon 0.22%
$287.35
price up icon 1.08%
drug_manufacturers_specialty_generic RDY
$15.03
price down icon 0.27%
$16.76
price up icon 0.00%
Kapitalisierung:     |  Volumen (24h):